US FDA Exploring Consortium To Develop Treatments For ‘Economically Infeasible’ Cancer Indications

 
• By Derrick Gingery

The FDA could partner with industry, academia and advocacy groups to speed development of novel treatments for cancers that are not commercially viable.

drug development
The public-private consortium could represent a substantial expansion of the FDA's Project Catalyst. • Source: Shutterstock

More from R&D

More from Pink Sheet